A differential equation based modelling approach to predict supersaturation and in vivo absorption from in vitro dissolution-absorption system (idas2) data

Eur J Pharm Biopharm. 2021 Aug:165:1-12. doi: 10.1016/j.ejpb.2021.05.003. Epub 2021 May 7.

Abstract

In vitro dissolution tests are widely used to monitor the quality and consistency of oral solid dosage forms, but to increase the physiological relevance of in vitro dissolution tests, newer systems combine dissolution and permeation measurements. Some of these use artificial membranes while others (e.g., in the in vitro dissolution absorption system 2; IDAS2), utilize cell monolayers to assess drug permeation. We determined the effect of the precipitation inhibitor Hypromellose Acetate Succinate (HPMCAS) on the supersaturation/permeation of Ketoconazole and Dipyridamole in IDAS2 and its effect on their absorption in rats. Thus the main objectives of this study were to determine: (1) whether dissolution and permeation data from IDAS2 could be used to predict rat plasma concentration using an absorption model and (2) whether the effect of the precipitation inhibitor HPMCAS on supersaturation and permeation in IDAS2 was correlated with its effect on systemic absorption in the rat. Predicted drug concentrations in rat plasma, generated using parameters estimated from IDAS2 dissolution/permeation data and a mathematical absorption model, showed good agreement with measured concentrations. While in IDAS2, the prolongation of Ketoconazole's supersaturation caused by HPMCAS led to higher permeation, which paralleled the higher systemic absorption in rats, Dipyridamole showed no supersaturation and, thus, no effect of HPMCAS in dissolution or permeation in IDAS2 and no effect on Dipyridamole absorption in rats. The ability of IDAS2 to detect supersaturation following a pH-shift supports the potential value of this system for studying approaches to enhance intestinal absorption through supersaturation and the accuracy of plasma concentration predictions in rats suggest the possibility of combining IDAS2 with absorption models to predict plasma concentration in different species.

Keywords: Absorption modelling; IDAS2; In vitro-In vivo correlation; In vivo predictive dissolution IPD; Supersaturation.

MeSH terms

  • Absorption, Physiological*
  • Administration, Oral
  • Animals
  • Caco-2 Cells
  • Dipyridamole / administration & dosage
  • Dipyridamole / pharmacokinetics
  • Drug Liberation*
  • Humans
  • Ketoconazole / administration & dosage
  • Ketoconazole / pharmacokinetics
  • Male
  • Models, Animal
  • Models, Biological*
  • Rats
  • Solubility

Substances

  • Dipyridamole
  • Ketoconazole